SCHEMBL3787590

SCHEMBL3787590

Nc1ccccc1-c1cccc(O)c1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
L3MBTL1 Q9Y468 3/20 0.59
ALOX15 P16050 3/20 0.54
TSHR P16473 1/20 0.54
HSD17B10 Q99714 3/20 0.44
CASP7 P55210 2/20 0.42
G6PD P11413 1/20 0.42
CASP6 P55212 1/20 0.42
NR1I2 O75469 2/20 0.42
SMARCA2 P51531 2/20 0.42
SMARCA4 P51532 2/20 0.42
PBRM1 Q86U86 2/20 0.42
BRD4 O60885 1/20 0.42
POLB P06746 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MCL1 Q07820 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564030 0.88 CASP7 (0.50) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL16986786 0.86 SMN1; SMN2 (0.48) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL6855517 0.84 ALOX15 (0.46) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL2068581 0.83 ALDH1A1 (0.68) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL11654081 0.83 ALDH1A1 (0.77) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL2929322 0.82 ALDH1A1 (0.59) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL6875810 0.82 ALOX15 (0.54) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL14578987 0.81 ALDH1A1 (0.65) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL2224609 0.80 ALDH1A1 (0.72) ALDH1A1L3MBTL1ALOX15TSHRHSD17B10
SCHEMBL6011670 0.79 PLAU (0.44) ALDH1A1L3MBTL1ALOX15TSHRCASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
US-5643986-A STORAGE STABLE, PROTECTIVE FILMS UBE INDUSTRIES, LTD. (JP) 1997-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885L3MBTL1 3838/4885ALOX15 1941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.